|
US2457405A
(en)
|
1945-09-25 |
1948-12-28 |
Monsanto Chemicals |
Halo nitroparaffin modified aminoplasts
|
|
US3261828A
(en)
|
1962-10-04 |
1966-07-19 |
Hoffmann La Roche |
3h-1,4-benzodiazepine-2,5(1h,4h)-dione compounds
|
|
US3374264A
(en)
|
1962-10-04 |
1968-03-19 |
Hoffmann La Roche |
N-haloacetyl-anthranilic acids and esters
|
|
US3415814A
(en)
|
1966-09-28 |
1968-12-10 |
Sterling Drug Inc |
4-(cyclopropylmethyl)-3h-1,4-benzodiazepine-2,5(1h,4h)-dione
|
|
US3384635A
(en)
|
1966-09-28 |
1968-05-21 |
Sterling Drug Inc |
1, 4-benzodiazepine derivatives
|
|
AT280290B
(de)
|
1967-11-24 |
1970-04-10 |
Boehringer Sohn Ingelheim |
Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen
|
|
US4108852A
(en)
|
1969-03-18 |
1978-08-22 |
Knoll Ag. |
Process for preparing 1,5-benzodiazepine-2-ones
|
|
USRE30293E
(en)
|
1969-03-18 |
1980-06-03 |
Knoll A.G. |
Process for preparing 1,5-benzodiazepine-2-ones
|
|
CH559729A5
(enExample)
|
1970-10-23 |
1975-03-14 |
Hoechst Ag |
|
|
GB1324469A
(en)
|
1970-10-28 |
1973-07-25 |
Knoll Ag |
Derivatives of benzodiazepines
|
|
ZA7465B
(en)
|
1973-01-16 |
1974-11-27 |
J Voorhees |
Proliferating skin diseases with acyl derivatives of cyclic adenosine monophosphate
|
|
IE38931B1
(en)
|
1973-03-09 |
1978-07-05 |
Lipha |
Triazolobenzodiazepines
|
|
US4076823A
(en)
|
1977-08-18 |
1978-02-28 |
E. R. Squibb & Sons, Inc. |
Triazolo-2,4-benzodiazepines
|
|
JPS59112984A
(ja)
|
1982-12-21 |
1984-06-29 |
Shionogi & Co Ltd |
１，４−ベンゾジアゼピン誘導体
|
|
US4495101A
(en)
|
1983-04-28 |
1985-01-22 |
American Home Products Corporation |
Antiinflammatory 5H-tetrazolo (5,1-c)(1,4)benzodiazepine derivatives
|
|
US4551480A
(en)
|
1983-06-21 |
1985-11-05 |
Stiefel Laboratories, Inc. |
Compositions for the treatment of psoriasis
|
|
US4894366A
(en)
|
1984-12-03 |
1990-01-16 |
Fujisawa Pharmaceutical Company, Ltd. |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
|
US5004741A
(en)
|
1984-06-26 |
1991-04-02 |
Merck & Co., Inc. |
Methods of antagonizing CCK or gastrin with benzodiazepine analogs
|
|
US4820834A
(en)
|
1984-06-26 |
1989-04-11 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
DE3435974A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
FR2591596B1
(fr)
|
1985-12-13 |
1988-09-09 |
Roussel Uclaf |
Nouvelles 4h-triazolo(4,3-a)(1,4)benzodiazepines, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
|
GB8608080D0
(en)
|
1986-04-02 |
1986-05-08 |
Fujisawa Pharmaceutical Co |
Solid dispersion composition
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4751223A
(en)
|
1986-10-14 |
1988-06-14 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines
|
|
US4898861A
(en)
|
1987-03-26 |
1990-02-06 |
Hoffmann-La Roche Inc. |
Method for inhibiting the proliferation of tumor cells
|
|
US5147872A
(en)
|
1987-06-09 |
1992-09-15 |
Golwyn Daniel H |
Treatment of immunologically based disorders, specifically psoriasis
|
|
US4970207A
(en)
|
1988-07-07 |
1990-11-13 |
Fujisawa Pharmaceutical Company, Ltd. |
Benzodiazepine derivatives
|
|
US5258510A
(en)
|
1989-10-20 |
1993-11-02 |
Otsuka Pharma Co Ltd |
Benzoheterocyclic compounds
|
|
US5041438A
(en)
|
1989-10-30 |
1991-08-20 |
Hoffmann-La Roche Inc. |
Method for treating retroviral infections with benzodiazepine compounds
|
|
US5324726A
(en)
|
1989-12-18 |
1994-06-28 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
|
ATE145208T1
(de)
|
1990-07-06 |
1996-11-15 |
Yoshitomi Pharmaceutical |
Kondensierte thiophenverbindungen und deren verwendung
|
|
BR9200951A
(pt)
|
1991-03-21 |
1992-11-17 |
Hoffmann La Roche |
Compostos, processo para sua producao,preparacoes farmaceuticas e uso
|
|
CA2130195A1
(en)
|
1992-03-16 |
1993-09-30 |
Mark Gary Bock |
Benzodiazepine derivatives, compositions containing them and their use in therapy
|
|
US5599352A
(en)
|
1992-03-19 |
1997-02-04 |
Medtronic, Inc. |
Method of making a drug eluting stent
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
GB9307527D0
(en)
|
1993-04-13 |
1993-06-02 |
Fujisawa Pharmaceutical Co |
New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
|
US5444092A
(en)
|
1994-07-20 |
1995-08-22 |
Collins; Jerry |
Method and composition for treating psoriasis
|
|
EP0804425A2
(en)
|
1994-07-29 |
1997-11-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzodiazepine derivatives
|
|
EP0776203A4
(en)
|
1994-08-18 |
1997-12-29 |
Merck & Co Inc |
N-2,3-DIHYDRO-1- (2-PROPYL) -2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPINE
|
|
US5618792A
(en)
|
1994-11-21 |
1997-04-08 |
Cortech, Inc. |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
|
|
AU5752696A
(en)
|
1995-05-18 |
1996-11-29 |
Regents Of The University Of Michigan, The |
Dna binding antibodies
|
|
US5677282A
(en)
|
1995-06-07 |
1997-10-14 |
Proscript, Inc. |
Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase
|
|
US5962337A
(en)
|
1995-06-29 |
1999-10-05 |
Pharmacopeia, Inc. |
Combinatorial 1,4-benzodiazepin-2,5-dione library
|
|
RU2096044C1
(ru)
|
1995-07-19 |
1997-11-20 |
Малое предприятие "Ветта" |
Ветеринарный имплантируемый препарат для регулирования биологического ритма животных
|
|
US5776946A
(en)
|
1995-08-28 |
1998-07-07 |
Mcgeer; Patrick L. |
Peripheral benzodiazepine receptor ligands as antiinflammatory agents
|
|
AU721860B2
(en)
|
1995-08-30 |
2000-07-13 |
La Jolla Institute For Allergy And Immunology |
Therapy for cellular accumulation in chronic inflammatory diseases
|
|
WO1997011061A1
(en)
|
1995-09-21 |
1997-03-27 |
Nikken Chemicals Co., Ltd. |
Compounds potentiating retinoid
|
|
US6579854B1
(en)
|
1996-08-14 |
2003-06-17 |
Vanderbilt University |
Diagnosis and management of infection caused by chlamydia
|
|
US7351421B2
(en)
|
1996-11-05 |
2008-04-01 |
Hsing-Wen Sung |
Drug-eluting stent having collagen drug carrier chemically treated with genipin
|
|
CA2274669C
(en)
|
1996-12-10 |
2006-11-14 |
Zeria Pharmaceutical Co., Ltd. |
1,5-benzodiazepine derivatives
|
|
US6074859A
(en)
|
1997-07-08 |
2000-06-13 |
Kikkoman Corporation |
Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
|
|
DE69840586D1
(de)
|
1997-10-08 |
2009-04-02 |
Isotechnika Inc |
Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
|
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
|
US6206914B1
(en)
|
1998-04-30 |
2001-03-27 |
Medtronic, Inc. |
Implantable system with drug-eluting cells for on-demand local drug delivery
|
|
FR2779963A1
(fr)
|
1998-06-22 |
1999-12-24 |
Centre Nat Rech Scient |
Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer
|
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
|
US20030044776A1
(en)
|
1998-09-25 |
2003-03-06 |
James A. Dykens |
Compositions and methods for identifying agents that alter mitochondrial permeability transition pores
|
|
FR2785803B1
(fr)
|
1998-11-17 |
2005-03-25 |
Sanofi Sa |
Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes
|
|
EP1156803A4
(en)
*
|
1999-02-09 |
2004-03-17 |
Bristol Myers Squibb Co |
FXA LACTAM INHIBITORS AND METHOD
|
|
US7175953B2
(en)
|
1999-04-09 |
2007-02-13 |
Institute Fuer Diagnostik Forschung |
Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
|
|
US7144880B2
(en)
|
1999-04-30 |
2006-12-05 |
Regents Of The University Of Michigan |
Compositions relating to novel compounds and targets thereof
|
|
US20040176358A1
(en)
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
|
US7276348B2
(en)
|
1999-04-30 |
2007-10-02 |
Regents Of The University Of Michigan |
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
|
|
US20050113460A1
(en)
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20030119029A1
(en)
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
IL146222A0
(en)
|
1999-04-30 |
2002-07-25 |
Univ Michigan |
Therapeutic applications of pro-apoptotic benzodiazepines
|
|
AU5826100A
(en)
|
1999-07-13 |
2001-01-30 |
F. Hoffmann-La Roche Ag |
Benzazepinones and quinazolines
|
|
CN1235875C
(zh)
*
|
1999-08-27 |
2006-01-11 |
西托维亚公司 |
取代的α－羟基酸天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途
|
|
US6524623B1
(en)
|
1999-11-12 |
2003-02-25 |
Milton Hodosh |
Therapeutic compositions and methods of use thereof
|
|
JP2003532757A
(ja)
|
2000-05-11 |
2003-11-05 |
イーストマン ケミカル カンパニー |
アシル化シクロデキストリン：ゲスト分子包接錯体
|
|
US6511973B2
(en)
*
|
2000-08-02 |
2003-01-28 |
Bristol-Myers Squibb Co. |
Lactam inhibitors of FXa and method
|
|
US20020048566A1
(en)
|
2000-09-14 |
2002-04-25 |
El-Deiry Wafik S. |
Modulation of cellular apoptosis and methods for treating cancer
|
|
WO2002047679A2
(en)
|
2000-12-15 |
2002-06-20 |
Emory University |
Nonpeptide agonists and antagonists of vasopressin receptors
|
|
IL159105A0
(en)
|
2001-06-07 |
2004-05-12 |
Neuro3D |
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
|
|
JP2005502652A
(ja)
|
2001-08-15 |
2005-01-27 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
新規ベンゾジアゼピン化合物に関連した組成物および方法、ならびにそれらの標的
|
|
AU2002357137A1
(en)
*
|
2001-12-10 |
2003-06-23 |
Bristol-Myers Squibb Company |
(1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
|
|
US20040009972A1
(en)
|
2002-06-17 |
2004-01-15 |
Ding Charles Z. |
Benzodiazepine inhibitors of mitochondial F1F0 ATP hydrolase and methods of inhibiting F1F0 ATP hydrolase
|
|
US7150433B2
(en)
|
2002-08-16 |
2006-12-19 |
Toyota Motor Sales, U.S.A., Inc. |
Aircraft bolster trays
|
|
US7109224B2
(en)
|
2002-11-06 |
2006-09-19 |
Bristol-Myers Squibb Co. |
Acyl guanidine compounds and use thereof
|
|
US20040087489A1
(en)
|
2002-11-06 |
2004-05-06 |
Antonio Ruiz |
Compositions and methods for the treatment of mycobacterial infections
|
|
WO2004050040A2
(en)
|
2002-12-03 |
2004-06-17 |
Vela Pharmaceuticals, Inc. |
Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
|
|
CA2508914A1
(en)
|
2002-12-04 |
2004-06-17 |
Gene Logic Inc. |
Modulators of melanocortin receptor
|
|
JP2007500212A
(ja)
|
2003-05-01 |
2007-01-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
新規化合物およびその標的に関する組成物および方法
|
|
US7351241B2
(en)
|
2003-06-02 |
2008-04-01 |
Carl Zeiss Meditec Ag |
Method and apparatus for precision working of material
|
|
US20090275099A1
(en)
|
2004-04-27 |
2009-11-05 |
Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20050272723A1
(en)
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
JP4990766B2
(ja)
|
2004-07-01 |
2012-08-01 |
シンタ ファーマシューティカルズ コーポレーション |
二置換型ヘテロアリール化合物
|
|
US20060052369A1
(en)
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20080314334A1
(en)
|
2004-11-10 |
2008-12-25 |
Garden Guardian, Inc. |
Device and Method for Controlling Animal Behavior
|
|
US7638624B2
(en)
|
2005-01-03 |
2009-12-29 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and derivatives
|
|
EP1893218A4
(en)
|
2005-06-01 |
2011-01-12 |
Univ Michigan |
UNLOCKED BENZODIAZEPINE COMPOSITIONS AND METHOD
|
|
EP1742460A1
(en)
|
2005-06-18 |
2007-01-10 |
TTE Germany GmbH |
Raster distortion correction circuit
|
|
AU2006306347A1
(en)
|
2005-10-26 |
2007-05-03 |
The Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
US20070105844A1
(en)
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
CA2628193C
(en)
|
2005-11-01 |
2012-08-14 |
The Regents Of The University Of Michigan |
Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
|
|
US7759338B2
(en)
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
|
EP2037741B1
(en)
|
2006-06-09 |
2013-11-27 |
The Regents Of The University Of Michigan |
Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders
|
|
GB0615068D0
(en)
|
2006-07-28 |
2006-09-06 |
Ttp Communications Ltd |
Digital radio systems
|
|
CN101662940A
(zh)
|
2007-03-09 |
2010-03-03 |
密执安州立大学董事会 |
与新化合物及其靶标有关的组合物和方法
|
|
JP5416122B2
(ja)
*
|
2007-09-14 |
2014-02-12 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ｆ１Ｆ０−ＡＴＰａｓｅインヒビターおよび関連の方法
|
|
RU2010122902A
(ru)
|
2007-11-06 |
2011-12-20 |
Дзе Риджентс оф дзе Юниверсити оф Мичиган (US) |
Бензодиапениноновые соединения, применимые в лечении кожных состояний
|